Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Jouinot

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Acta Neurochirurgica|September 22, 2023
Pituitary surgery outcome in patients 75 years and older: a retrospective studyMarta Garvayo, Chiara Villa, Anne Jouinot, et al.
European Journal of Endocrinology|July 6, 2024
Whole blood transcriptomic signature of Cushing's syndromeMaria Francesca Birtolo, Roberta Armignacco, Nesrine Benanteur, et al.
Neurosurgical Review|June 5, 2025
Specific focus on the basal dura for improving Cushing's disease surgery: a cohort studyBertrand Baussart, Benoit Hudelist, Chiara Villa, et al.
Cancers|July 9, 2022
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with NivolumabJohanna Noel, Anne Jouinot, Jérôme Alexandre, et al.
European Journal of Endocrinology|June 22, 2026
The Polystyrene Beads Sign: A Simple MRI Marker for the Preoperative Diagnosis of Papillary Hypothalamic CraniopharyngiomasBertrand Baussart, Arianna Fava, Maxime Barat, et al.
The Journal of Molecular Diagnostics : JMD|August 23, 2017
Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?Simon Garinet, Mario Néou, Bruno de La Villéon, et al.
European Journal of Endocrinology|October 27, 2025
Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatmentFabio Bioletto, Nesrine Benanteur, Maria Francesca Birtolo, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2021
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk managementAudrey Bellesoeur, Ithar Gataa, Anne Jouinot, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 4, 2025
A Computed Tomography-Based Score to Predict Survival in Patients With Adrenocortical Carcinoma: A Proof-of-Concept StudyMaxime Barat, Mohamed Eltaher, Ahmed W Moawad, et al.
Cancers|February 23, 2020
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control StudyManuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Acta Neurochirurgica|September 22, 2023
Pituitary surgery outcome in patients 75 years and older: a retrospective studyMarta Garvayo, Chiara Villa, Anne Jouinot, et al.
European Journal of Endocrinology|July 6, 2024
Whole blood transcriptomic signature of Cushing's syndromeMaria Francesca Birtolo, Roberta Armignacco, Nesrine Benanteur, et al.
Neurosurgical Review|June 5, 2025
Specific focus on the basal dura for improving Cushing's disease surgery: a cohort studyBertrand Baussart, Benoit Hudelist, Chiara Villa, et al.
Cancers|July 9, 2022
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with NivolumabJohanna Noel, Anne Jouinot, Jérôme Alexandre, et al.
European Journal of Endocrinology|June 22, 2026
The Polystyrene Beads Sign: A Simple MRI Marker for the Preoperative Diagnosis of Papillary Hypothalamic CraniopharyngiomasBertrand Baussart, Arianna Fava, Maxime Barat, et al.
The Journal of Molecular Diagnostics : JMD|August 23, 2017
Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?Simon Garinet, Mario Néou, Bruno de La Villéon, et al.
European Journal of Endocrinology|October 27, 2025
Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatmentFabio Bioletto, Nesrine Benanteur, Maria Francesca Birtolo, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2021
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk managementAudrey Bellesoeur, Ithar Gataa, Anne Jouinot, et al.
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|May 4, 2025
A Computed Tomography-Based Score to Predict Survival in Patients With Adrenocortical Carcinoma: A Proof-of-Concept StudyMaxime Barat, Mohamed Eltaher, Ahmed W Moawad, et al.
Cancers|February 23, 2020
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control StudyManuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, et al.
Pageof 9